NM_002755.4:c.-216_-215dupCG
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_002755.4(MAP2K1):c.-216_-215dupCG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00605 in 371,492 control chromosomes in the GnomAD database, including 50 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 47 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 3 hom. )
Consequence
MAP2K1
NM_002755.4 5_prime_UTR
NM_002755.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.818
Publications
0 publications found
Genes affected
MAP2K1 (HGNC:6840): (mitogen-activated protein kinase kinase 1) The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. [provided by RefSeq, Jul 2008]
MAP2K1 Gene-Disease associations (from GenCC):
- cardiofaciocutaneous syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- cardiofaciocutaneous syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
- Noonan syndrome with multiple lentiginesInheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, ClinGen
- Noonan syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 15-66387126-T-TGC is Benign according to our data. Variant chr15-66387126-T-TGC is described in ClinVar as [Likely_benign]. Clinvar id is 316834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0588 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0132 AC: 1858AN: 141064Hom.: 47 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1858
AN:
141064
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00168 AC: 387AN: 230294Hom.: 3 Cov.: 2 AF XY: 0.00136 AC XY: 165AN XY: 121652 show subpopulations
GnomAD4 exome
AF:
AC:
387
AN:
230294
Hom.:
Cov.:
2
AF XY:
AC XY:
165
AN XY:
121652
show subpopulations
African (AFR)
AF:
AC:
262
AN:
4016
American (AMR)
AF:
AC:
15
AN:
5030
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
5610
East Asian (EAS)
AF:
AC:
0
AN:
11868
South Asian (SAS)
AF:
AC:
1
AN:
13294
European-Finnish (FIN)
AF:
AC:
0
AN:
31524
Middle Eastern (MID)
AF:
AC:
3
AN:
1036
European-Non Finnish (NFE)
AF:
AC:
30
AN:
144738
Other (OTH)
AF:
AC:
74
AN:
13178
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0132 AC: 1862AN: 141198Hom.: 47 Cov.: 33 AF XY: 0.0127 AC XY: 870AN XY: 68568 show subpopulations
GnomAD4 genome
AF:
AC:
1862
AN:
141198
Hom.:
Cov.:
33
AF XY:
AC XY:
870
AN XY:
68568
show subpopulations
African (AFR)
AF:
AC:
1785
AN:
39744
American (AMR)
AF:
AC:
49
AN:
14404
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3290
East Asian (EAS)
AF:
AC:
0
AN:
3952
South Asian (SAS)
AF:
AC:
0
AN:
3814
European-Finnish (FIN)
AF:
AC:
0
AN:
8736
Middle Eastern (MID)
AF:
AC:
1
AN:
282
European-Non Finnish (NFE)
AF:
AC:
12
AN:
64096
Other (OTH)
AF:
AC:
15
AN:
2026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
83
165
248
330
413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3474
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cardio-facio-cutaneous syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Oct 16, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Noonan syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.